Why you should be offering your employees estate and legacy planning tools. Photo courtesy of The Postage

As priorities for employees have shifted as part of the Great Resignation the need for non-traditional benefits has continued to arise. Employees are expecting their personal and family wellness to be at the core of what their employers are offering. This is a big consideration when deciding to stay or leave a company. While HR professionals and employers are realizing they need to re-evaluate their benefits and how they keep top talent, there’s one key benefit that is typically missed that is a life necessity for all, estate and legacy planning.

Given today’s uber competitive talent market, there’s an opportunity for companies to embrace new benefits that go beyond the typical and support vital needs, such as financial wellness and estate planning. Taking the next step by providing and connecting employees with the right resources can make all the difference. Estate and legacy planning goes beyond creating a will, it’s about end to end care of life and legacy. It helps transition wealth and wisdom across generations. It handles your affairs, finances, your digital assets, protects your children and pets, and ensures your wishes are carried out if you are temporarily unavailable or permanently incapable of handling them. It’s as critical and as necessary as insurance yet is not typically included as a key employee benefit.

Why should you add estate and legacy planning as part of your employee benefits? Here’s the top three reasons to consider:

1. Create value for your employees and their families

Financial wellness and security are the utmost important for employees. In fact, it’s one of the most-valued benefits, based on a recent survey Morgan Stanley found that 90 percent of employees want their company to prioritize financial benefits. Are you going to be one of the 95 percent of HR executives that plan to do so? If so, there are multiple ways that a company can help its employees to build wealth and protect their financial security through traditional benefits such as retirement savings plans, health insurance, voluntary life, and disability insurance, and more. But additional benefits like estate and legacy planning should be a part of this assortment of benefits that support protecting employees and their families’ finances - by helping them build and protect their financial and personal legacies.

Employers can show that they value and support their employee’s financial success and security by providing tools and resources that make it simple to handle these historically daunting tasks and keep them organized throughout life, which allows employees to have peace of mind for their families’ future, financial and beyond.

2. Stand out among your competitors

Most employers do not provide legacy and estate planning services. Only 12 percent of employers provide these types of benefits, yet over 72 percent of those who are not offered estate planning services by their employer, would be interested in using them if offered. That’s a huge percentage of your employee population that would benefit from this service while differentiating you from other employers and provide an opportunity for your company to show just how much you value your employees’ futures.

3. Show you care about your employees

More people have begun to self-reflect on what is truly important to them as a part of the Great Resignation. Now, employee desires have evolved beyond a high salary with decent benefits. Employees want to feel valued beyond the work they do, and even further than that, they need an environment where their career, their loved ones, and their own being is supported. These psychological needs are translating into demands for companies to provide more thoughtful employee benefits packages.

A study conducted by Morgan Stanley shows how perceptions of employees and HR executives alike have transformed, with 9 in 10 HR executives saying their company needs to do a better job helping employees understand how to maximize their financial benefits. Proving to your employees that you care about them beyond the ‘now’beyond simply providing short-term benefits that exclusively affect them in the present day–leverages your company’s commitment to caring for your workers.

For people that struggle with organizing their property and wealth, estate planning can help visualize their total net worth. However, benefits that not only anticipate employees’ future financial needs but also organize their family network will drive continual engagement within your company and prove genuine care for your workers. For example, The Postage helps people plan their legacy. On top of estate planning, customers also have the ability to store and document important life events and memories, or even utilize our message planning feature where they can send timely notes to their family at a future date.

Employees want to feel valued beyond their work and taking the steps to help them build physical and financial legacies for both themselves and their loved ones will put your company one step ahead of everyone else. It is time for estate planning to join the conversation for employee benefits packages and helping employees proactively plan their future could be the cornerstone of attracting and retaining diverse talent.

------

Emily Cisek is the founder and CEO of The Postage, a tech-enabled, easy-to-use estate planning tool.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

New UH survey reveals concerns over AI data center growth in Houston

data findings

A new report out of the University of Houston shows that area residents remain wary of the long-term effects of operating data centers.

The recent survey from the University of Houston’s latest SPACE City Panel, conducted by the Center for Public Policy at the Hobby School of Public Affairs, shows that while 85 percent of Houston-area residents use AI, nearly 63 percent oppose the construction of AI data centers within 1 mile of their homes.

Respondents’ concerns centered around data centers’ high energy demand and the area’s power grid reliability. According to the survey, 32 percent of residents who oppose local data center projects would be more likely to support the centers if they relied on renewable energy over fossil fuels.

“Respondents understand that AI can bring economic and educational benefits, but they are also concerned about the physical infrastructure needed to fuel AI, especially data centers,” Soran Mohtadi, post-doctoral fellow at the Hobby School and a researcher on the report, said in a news release. “This physical infrastructure demands more electricity and water, leading to environmental impacts.”

Experts estimate that 6.5 gigawatts of data center capacity will be added to the Texas grid by 2030. And Houston’s data center capacity is predicted to more than double by 2028.

The Electric Reliability Council of Texas also projects electricity demand could reach 218 gigawatts by 2031, which would be more than double the record peak set in August 2023. Data centers are expected to account for 86 gigawatts of that new demand.

Survey respondents also said they are concerned about the state's future water supply, given the large amounts of water that data centers need to stay cool.

In terms of who’s responsible for that issue, 57.6 percent of respondents said they put the onus on Texas lawmakers, while 31.5 percent say tech companies should be responsible.

Additionally, more than 75 percent of respondents believed that data center developers and technology companies—not residents—should bear the cost of infrastructure upgrades to support data centers.

“Every decision legislators make has implications on residents’ everyday lives and local infrastructure now and in the future,” Maria P. Perez Arguelles, lead researcher on the report and research assistant professor at the Hobby School, added in the news release. “This issue is going to become more important in years to come, so this is just the beginning.”

Read the full report here.

Houston-born Cemvita makes breakthrough in sustainable fuel production

clean fuels

Houston-based biotech company Cemvita announced that it recently reached a critical milestone in the development of its FermOil product, which can be used to create Sustainable Aviation Fuel (SAF) and other renewable fuels at industrial scale.

The company shared in a news release that it completed a 75,000-liter industrial fermentation run at Belgium's Bio Base Europe Pilot Plant.

The campaign achieved target technical metrics for the production of FermOil, Cemvita’s renewable natural oil (RNO). FermOil is produced from industrial crude glycerin, an industrial byproduct, as opposed to traditional sugar-based feedstocks used in many bio-oil fermentation processes. It's designed to be a drop-in feedstock for creating SAFs.

Cemvita had previously advanced its FermOil production process through multiple scale-up stages before successfully reaching the 75,000-liter demonstration campaign, according to the company.

“This is not just a fermentation milestone,” Moji Karimi, CEO at Cemvita, said in the release. “It is a blueprint for how existing industrial infrastructure can evolve into circular bioeconomy infrastructure. Every biodiesel plant generating crude glycerin is a potential platform for renewable natural oil production.”

The milestone also supports the deployment of Cemvita’s industrial biomanufacturing platform, FermWorks, which integrates with existing energy and industrial infrastructure to turn waste carbon streams into SAFs and other materials. According to the release, Cemvita plans to move forward with commercial deployment discussions with partners in Brazil, Europe and in the UK. Cemvita already has a partnership with the Brazilian sustainable research institution REMA.

“We are proud to support innovative companies like Cemvita in scaling breakthrough industrial biotechnology solutions,” Hendrik Waegeman, head of business operations at Bio Base Europe Pilot Plant, added in the release. “Successfully operating at the 75,000-liter scale using a feedstock such as crude glycerin highlights both the maturity of the technology and the quality of the scale-up execution achieved by the Cemvita team.”

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Eli Lilly scoops up Houston biotech startup in $300 million deal

big pharma deal

Pharmaceutical giant Eli Lilly has acquired Houston biotech startup CrossBridge Bio, which develops antibody-drug conjugates for cancer, in a deal worth up to $300 million. The deal was celebrated by TMC Venture Fund and the University of Texas Health Science Center at Houston last week.

CrossBridge, founded in 2023, is developing ADCs based on research by Kyoji Tsuchikama and Zhiqiang An, both of UT Health Houston. Tsuchikama is an associate professor of medicinal chemistry and a globally recognized ADC pioneer, and An is a professor of molecular science and vice president of drug discovery.

Antibody-drug conjugates (ADCs) are a potent combination of targeted therapy and chemotherapy that kills cancer cells while saving healthy tissue.

Clinical trials for CrossBridge’s primary ADC candidate, CBB-120, are expected to start this year, pending approval from the U.S. Food and Drug Administration (FDA).

“I’m proud of how well our team has executed and advanced our platform in such a short time since the company’s founding,” Michael Torres, co-founder and CEO of CrossBridge, said in a news release. “By becoming a part of Lilly, a leader in patient-focused therapeutic development, we are well-positioned to further accelerate the clinical potential of this approach.”

Under the Lilly deal, CrossBridge shareholders were expected to receive an upfront payment along with a follow-up payment based on the achievement of certain milestones.

In 2024, CrossBridge closed a $10 million seed round. Among the investors in CrossBridge are the Texas Medical Center Venture Fund, CE-Ventures, Alexandria Venture Investments, Portal Innovations, Linden Lake Labs, and the Cancer Prevention and Research Institute of Texas (CPRIT). It was formed in TMC Innovation’s Accelerator for Cancer Therapeutics program."Built within the TMC ecosystem, CrossBridge Bio grew with the support, funding, and resources that helped shape its trajectory. TMC led the company's early financing and watched it evolve from its earliest days to its acquisition by Eli Lilly," William McKeon, president and CEO of the Texas Medical Center, shared in a LinkedIn post. "[This is a] strong reminder that breakthrough science and the right early backing can change what’s possible."